232 related articles for article (PubMed ID: 26731754)
1. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.
Hileman CO; Turner R; Funderburg NT; Semba RD; McComsey GA
AIDS; 2016 Jan; 30(1):65-73. PubMed ID: 26731754
[TBL] [Abstract][Full Text] [Related]
2. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
Hileman CO; Tangpricha V; Sattar A; McComsey GA
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):539-547. PubMed ID: 28045766
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
Longenecker CT; Sattar A; Gilkeson R; McComsey GA
AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
[TBL] [Abstract][Full Text] [Related]
4. HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.
Hale AT; Longenecker CT; Jiang Y; Debanne SM; Labatto DE; Storer N; Hamik A; McComsey GA
AIDS; 2015 Aug; 29(13):1643-50. PubMed ID: 26372274
[TBL] [Abstract][Full Text] [Related]
5. Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.
Nou E; Lu MT; Looby SE; Fitch KV; Kim EA; Lee H; Hoffmann U; Grinspoon SK; Lo J
AIDS; 2016 Feb; 30(4):583-90. PubMed ID: 26558731
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
Dirajlal-Fargo S; Kinley B; Jiang Y; Longenecker CT; Hileman CO; Debanne S; McComsey GA
AIDS; 2015 Jan; 29(3):313-21. PubMed ID: 25686680
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
[TBL] [Abstract][Full Text] [Related]
8. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
9. Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.
Hileman CO; McComsey GA
AIDS Res Hum Retroviruses; 2018 Mar; 34(3):282-285. PubMed ID: 28974102
[TBL] [Abstract][Full Text] [Related]
10. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
Funderburg NT; Jiang Y; Debanne SM; Labbato D; Juchnowski S; Ferrari B; Clagett B; Robinson J; Lederman MM; McComsey GA
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):396-404. PubMed ID: 25514794
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
13. Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.
Morrison JT; Longenecker CT; Mittelsteadt A; Jiang Y; Debanne SM; McComsey GA
HIV Clin Trials; 2016 Jul; 17(4):140-6. PubMed ID: 27294339
[TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis.
Wagner S; Apetrii M; Massy ZA; Kleber ME; Delgado GE; Scharnagel H; März W; Metzger M; Rossignol P; Jardine A; Holdaas H; Fellström B; Schmieder R; Stengel B; Zannad F;
Free Radic Res; 2017 Jan; 51(1):14-23. PubMed ID: 27667446
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
Longenecker CT; Hileman CO; Funderburg NT; McComsey GA
Clin Infect Dis; 2014 Oct; 59(8):1148-56. PubMed ID: 25015912
[TBL] [Abstract][Full Text] [Related]
16. Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Kei A; Tellis C; Liberopoulos E; Tselepis A; Elisaf M
Cardiovasc Ther; 2014 Aug; 32(4):139-46. PubMed ID: 24618208
[TBL] [Abstract][Full Text] [Related]
17. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
[TBL] [Abstract][Full Text] [Related]
18. Plasma Selenium Concentrations Are Sufficient and Associated with Protease Inhibitor Use in Treated HIV-Infected Adults.
Hileman CO; Dirajlal-Fargo S; Lam SK; Kumar J; Lacher C; Combs GF; McComsey GA
J Nutr; 2015 Oct; 145(10):2293-9. PubMed ID: 26269240
[TBL] [Abstract][Full Text] [Related]
19. Effect of statin on arginine metabolites in treated HIV-infection.
Dirajlal-Fargo S; El Kamari V; Sattar A; Alam K; Funderburg N; Labbato D; Pirro L; Longenecker CT; Wilson WH; McComsey GA
Atherosclerosis; 2017 Nov; 266():74-80. PubMed ID: 28992467
[TBL] [Abstract][Full Text] [Related]
20. Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
Zidar DA; Juchnowski S; Ferrari B; Clagett B; Pilch-Cooper HA; Rose S; Rodriguez B; McComsey GA; Sieg SF; Mehta NN; Lederman MM; Funderburg NT
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):154-60. PubMed ID: 25647528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
